First AD

Second AD

Scientific Interchange & Workshop

® Scientific Workshops and Interchanges bring together subject matter experts to discuss the landscape and the clinical advancements in the treatment of patients with various malignancies. These workshops are designed to produce an interactive environment where the invited faculty share insights and their perceptions around the management of selected cancer types.

Current and Emerging Trends in  Breast Cancer: HER2+ and HER2-Low

This publication provides a summary of key stakeholder insights on the role of antibody-drug conjugates in targeting HER2+ or HER2-low breast cancer and examines clinical trial data on treatment options for HER2+ breast cancer with brain metastases. 